Clinical Trial Update: Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating precise endoscopic application of nitroglycerin to prevent post-ERCP pancreatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Pancreatitis | Phase 4 | Status: RECRUITING